NCT02402725View on ClinicalTrials.gov

A Open-label Study of Ultra-High Dose Dexamethasone for Relapsed Multiple Myeloma

PHASE2WithdrawnINTERVENTIONAL

Timeline

Start Date

May 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions

Multiple Myeloma

Interventions

DRUG

Dexamethasone

(1 cycle = 28 days) D1: Dexamethasone 100mg IV; Dex 24mg PO every 6 hrs (begin immediately after IV dex) D2: Dex 24mg PO every 6 hrs D3: Dex 24mg PO every 6 hrs

Trial Locations (1)

02118

Boston Medical Center, Boston